{"entity":{"type":"insider","cik":"0001808322","url":"/insider/0001808322","json_url":"/insider/0001808322.json","name":"Lachey Jennifer","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":17,"first":"2021-02-16","last":"2022-07-19","span_basis":"filed_date"},"name_variants":[{"name":"Lachey Jennifer","source":"filing","n_filings":17,"first_seen":"2021-02-16","last_seen":"2022-07-19"}],"transactions":[{"id":6352878,"accession":"0001209191-22-042573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-042573","line_url":"/filing/0001209191-22-042573#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46034.0,"shares_display":"46,034","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":1381020.0,"total_display":"1,381,020.00","total_whole":"1,381,020","shares_owned_after":95100.0,"shares_owned_after_display":"95,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-19","scope":"insider"},{"id":6925717,"accession":"0001209191-22-042253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-042253","line_url":"/filing/0001209191-22-042253#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1916.0,"shares_display":"1,916","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":57480.0,"total_display":"57,480.00","total_whole":"57,480","shares_owned_after":95100.0,"shares_owned_after_display":"95,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-13","filed_date":"2022-07-15","scope":"insider"},{"id":6924965,"accession":"0001209191-22-028889","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-028889","line_url":"/filing/0001209191-22-028889","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":41.896152830188676,"price_display":"41.90","price_state":"stated","total_value":222049.61,"total_display":"222,049.61","total_whole":"222,050","shares_owned_after":87602.0,"shares_owned_after_display":"87,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-13","scope":"insider","n_lines":5},{"id":6543271,"accession":"0001209191-22-024290","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-024290","line_url":"/filing/0001209191-22-024290","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":62.774437735849055,"price_display":"62.77","price_state":"stated","total_value":332704.52,"total_display":"332,704.52","total_whole":"332,705","shares_owned_after":86259.0,"shares_owned_after_display":"86,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-13","scope":"insider","n_lines":4},{"id":6369166,"accession":"0001209191-22-023494","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-023494","line_url":"/filing/0001209191-22-023494#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7950.0,"shares_display":"7,950","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":477000.0,"total_display":"477,000.00","total_whole":"477,000","shares_owned_after":85700.0,"shares_owned_after_display":"85,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-06","scope":"insider"},{"id":6723938,"accession":"0001209191-22-018836","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-018836","line_url":"/filing/0001209191-22-018836","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":53.376920754716984,"price_display":"53.38","price_state":"stated","total_value":141448.84,"total_display":"141,448.84","total_whole":"141,449","shares_owned_after":87288.0,"shares_owned_after_display":"87,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-15","scope":"insider","n_lines":3},{"id":6242909,"accession":"0001209191-22-009792","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-009792","line_url":"/filing/0001209191-22-009792","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":52.062150943396226,"price_display":"52.06","price_state":"stated","total_value":137964.7,"total_display":"137,964.70","total_whole":"137,965","shares_owned_after":85899.0,"shares_owned_after_display":"85,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-15","scope":"insider","n_lines":3},{"id":6094485,"accession":"0001209191-22-003198","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-003198","line_url":"/filing/0001209191-22-003198","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":53.753683018867925,"price_display":"53.75","price_state":"stated","total_value":142447.26,"total_display":"142,447.26","total_whole":"142,447","shares_owned_after":86834.0,"shares_owned_after_display":"86,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider","n_lines":3},{"id":6564446,"accession":"0001209191-22-002416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-002416","line_url":"/filing/0001209191-22-002416#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":159000.0,"total_display":"159,000.00","total_whole":"159,000","shares_owned_after":85700.0,"shares_owned_after_display":"85,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":4106265,"accession":"0001209191-21-069767","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-069767","line_url":"/filing/0001209191-21-069767#line-6","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":735.0,"shares_display":"735","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":36750.0,"total_display":"36,750.00","total_whole":"36,750","shares_owned_after":85700.0,"shares_owned_after_display":"85,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-15","scope":"insider"},{"id":4106259,"accession":"0001209191-21-069767","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-069767","line_url":"/filing/0001209191-21-069767","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1915.0,"shares_display":"1,915","price_per_share":50.55261618798956,"price_display":"50.55","price_state":"stated","total_value":96808.26,"total_display":"96,808.26","total_whole":"96,808","shares_owned_after":86097.0,"shares_owned_after_display":"86,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider","n_lines":3},{"id":5299459,"accession":"0001209191-21-064218","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-064218","line_url":"/filing/0001209191-21-064218","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":59.63359433962264,"price_display":"59.63","price_state":"stated","total_value":316058.05,"total_display":"316,058.05","total_whole":"316,058","shares_owned_after":85700.0,"shares_owned_after_display":"85,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-12","scope":"insider","n_lines":2},{"id":5299452,"accession":"0001209191-21-064218","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-064218","line_url":"/filing/0001209191-21-064218#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15900.0,"shares_display":"15,900","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":954000.0,"total_display":"954,000.00","total_whole":"954,000","shares_owned_after":85700.0,"shares_owned_after_display":"85,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider"},{"id":4105444,"accession":"0001209191-21-063210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-063210","line_url":"/filing/0001209191-21-063210#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10600.0,"shares_display":"10,600","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":530000.0,"total_display":"530,000.00","total_whole":"530,000","shares_owned_after":85700.0,"shares_owned_after_display":"85,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-05","scope":"insider"},{"id":4668546,"accession":"0001209191-21-040651","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-040651","line_url":"/filing/0001209191-21-040651","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":50.976309433962264,"price_display":"50.98","price_state":"stated","total_value":135087.22,"total_display":"135,087.22","total_whole":"135,087","shares_owned_after":79024.0,"shares_owned_after_display":"79,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-15","scope":"insider","n_lines":3},{"id":4784848,"accession":"0001209191-21-032358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-032358","line_url":"/filing/0001209191-21-032358#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":132500.0,"total_display":"132,500.00","total_whole":"132,500","shares_owned_after":71187.0,"shares_owned_after_display":"71,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":4138981,"accession":"0001209191-21-026666","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-026666","line_url":"/filing/0001209191-21-026666","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":60.00497924528302,"price_display":"60.00","price_state":"stated","total_value":318026.39,"total_display":"318,026.39","total_whole":"318,026","shares_owned_after":72016.0,"shares_owned_after_display":"72,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-14","scope":"insider","n_lines":4},{"id":5146863,"accession":"0001209191-21-020480","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-020480","line_url":"/filing/0001209191-21-020480","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":64.48104339622641,"price_display":"64.48","price_state":"stated","total_value":341749.53,"total_display":"341,749.53","total_whole":"341,750","shares_owned_after":61195.0,"shares_owned_after_display":"61,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-11","filed_date":"2021-03-15","scope":"insider","n_lines":3},{"id":5190561,"accession":"0001209191-21-010880","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-010880","line_url":"/filing/0001209191-21-010880","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001808322","owner_name":"Lachey Jennifer","owner_display_name":"Lachey Jennifer","owner_url":"/insider/0001808322","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":64.9088037735849,"price_display":"64.91","price_state":"stated","total_value":344016.66,"total_display":"344,016.66","total_whole":"344,017","shares_owned_after":28267.0,"shares_owned_after_display":"28,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001664710","name":"Keros Therapeutics, Inc.","url":"/issuer/0001664710","role":"Officer (Chief Scientific Officer)","n_filings":17,"first_seen":"2021-02-16","last_seen":"2022-07-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808322","retrieved_at":"2026-08-24T03:53:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}